Abstract
Background
Bronchopulmonary dysplasia (BPD) is a common chronic respiratory disease in preterm infants. NLRP3-mediated macrophage pyroptosis plays a crucial role in the pathogenesis of BPD. Recent evidence suggests that betaine has anti-inflammatory and antioxidant functions. This study aimed to investigate the effect of betaine on pulmonary macrophage pyroptosis in BPD.
Methods
Newborn mice were exposed to either hyperoxia (90%) or room air shortly after birth and treated subcutaneously with betaine daily for 14 days. Lung development, the expression of macrophage pyrolysis-associated proteins and the phospho-forkhead box O1 (p-FOXO1) were evaluated. In vitro, the effect of betaine on the expression of p-FOXO1 was assessed in RAW264.7 macrophages exposed to either 90% oxygen or 21% oxygen, with okadaic acid (OA) as phosphatase inhibitor.
Results
Hyperoxia induced macrophage pyroptosis and impaired lung development in newborn mice. Betaine inhibited p-FOXO1 expression and NLRP3-mediated pyroptosis in pulmonary and promoted lung development in the hyperoxia-exposed mice. In vitro, betaine suppressed FOXO1 phosphorylation and NLRP3-mediated pyroptosis under 90% oxygen in RAW264.7 cells, and OA administration reversed these effects.
Conclusion
Betaine may reduce the expression of inflammatory cytokines, downregulate macrophage pyroptosis by inhibiting the phosphorylation of FOXO1, and improve lung development in BPD.
Impact
-
Our previous research showed that plasma betaine levels at 36 weeks postmenstrual age (PMA) were significantly lower in preterm infants with BPD compared to those without BPD.
-
Betaine has anti-inflammatory and antioxidant functions. However, its role in pulmonary macrophage pyroptosis in BPD remains unknown.
-
The study shows that betaine may downregulate macrophage pyroptosis by inhibiting FOXO1 phosphorylation, alleviate lung inflammation, and improve lung development in BPD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
Data availability
The datasets used or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Bell, E. F. et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018. Jama 327, 248–263 (2022).
Thébaud, B. et al. Bronchopulmonary dysplasia. Nat. Rev. Dis. Prim. 5, 78 (2019).
Dankhara, N., Holla, I., Ramarao, S. & Kalikkot Thekkeveedu, R. Bronchopulmonary dysplasia: pathogenesis and pathophysiology. J. Clin. Med.12, 4207 (2023).
You, Y. et al. Early metabolic markers as predictors of respiratory complications in preterm infants with bronchopulmonary dysplasia. Early Hum. Dev. 190, 105950 (2024).
Zhao, G. et al. Betaine in inflammation: mechanistic aspects and applications. Front Immunol. 9, 1070 (2018).
Day, C. R. & Kempson, S. A. Betaine chemistry, roles, and potential use in liver disease. Biochim Biophys. Acta Gen. Subj. 1860, 1098–1106 (2016).
Rehman, A. & Mehta, K. J. Betaine in ameliorating alcohol-induced hepatic steatosis. Eur. J. Nutr. 61, 1167–1176 (2021).
Arora, S. et al. Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology 223, 383–396 (2018).
Tu, Z. et al. Detection and significance of macrophage pyroptosis in a hyperoxia-exposed BPD mouse model. Fudan Univ. J. Med. Sci. 11, 791–801 (2023).
Calissi, G. et al. Therapeutic strategies targeting FOXO transcription factors. Nat. Rev. Drug Discov. 20, 21–38 (2020).
Zhao, H., Qin, L., Wang, R., Qu, D. & Li, S. Foxo1 regulates Nlrp3 inflammasome proteins in LPS-induced cardiotoxicity. Am. J. Transl. Res. 15, 5446–5456 (2023).
Wang, Y., Chen, S. & Li, H. Hydrogen peroxide stress stimulates phosphorylation of FOXO1 in rat aortic endothelial cells. Acta Pharm. Sin. 31, 160–164 (2010).
Kim, D. H. et al. Effect of betaine on hepatic insulin resistance through Foxo1-induced Nlrp3 inflammasome. J. Nutr. Biochem. 45, 104–114 (2017).
Liu, C. et al. Itaconic acid regulation of TFEB-mediated autophagy flux alleviates hyperoxia-induced bronchopulmonary dysplasia. Redox Biol. 72, 103115 (2024).
Yee, M. et al. Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. Am. J. Pathol. 178, 2601–2610 (2011).
Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).
Hossain, M. E. et al. Hypertensive rats show increased renal excretion and decreased tissue concentrations of glycine betaine, a protective osmolyte with diuretic properties. Plos One 19, e0294926 (2024).
Yan, L. et al. Pp2a regulates the pro-apoptotic activity of Foxo1. J. Biol. Chem. 283, 7411–7420 (2008).
Guo, Y. et al. Betaine effects on morphology, proliferation, and p53-induced apoptosis of HeLa cervical carcinoma cells in vitro. Asian Pac. J. Cancer Prev. 16, 3195–3201 (2015).
Gilfillan, M., Bhandari, A. & Bhandari, V. Diagnosis and management of bronchopulmonary dysplasia. BMJ 375, n1974 (2021).
Hwang, J. S. & Rehan, V. K. Recent advances in bronchopulmonary dysplasia: pathophysiology, prevention, and treatment. Lung 196, 129–138 (2018).
Kesavardhana, S., Malireddi, R. K. S. & Kanneganti, T. D. Caspases in cell death, inflammation, and pyroptosis. Annu Rev. Immunol. 38, 567–595 (2020).
Deng, X. et al. Molecular mechanisms of cell death in bronchopulmonary dysplasia. Apoptosis 28, 39–54 (2022).
Coll, R. C., Schroder, K. & PelegrÃn, P. Nlrp3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharm. 43, 653–668 (2022).
Dapaah-Siakwan, F. et al. Caspase-1 inhibition attenuates hyperoxia-induced lung and brain injury in neonatal mice. Am. J. Respir. Cell Mol. Biol. 61, 341–354 (2019).
Liu, P. et al. Mesenchymal stem cells-derived exosomes alleviate acute lung injury by inhibiting alveolar macrophage pyroptosis. Stem Cells Transl. Med. 13, 371–386 (2024).
Sonny, S. et al. Gsdmd deficiency ameliorates hyperoxia-induced BPD and ROP in neonatal mice. Sci. Rep. 13, 143 (2023).
Liao, J. et al. The Nlrp3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nat. Commun. 6, 8977 (2015).
Xing, Y. et al. The regulation of Foxo1 and its role in disease progression. Life Sci. 193, 124–131 (2018).
Rong, S. J. et al. The essential role of FOXO1 in the regulation of macrophage function. Biomed. Res. Int 2022, 1068962 (2022).
Tan, X. et al. Punicalagin ameliorates diabetic liver injury by inhibiting pyroptosis and promoting autophagy via modulation of the FOXO1/TXNIP signaling pathway. Mol. Nutr. Food Res 68, e2300912 (2024).
Zhang, Y. et al. Microcystin-Lr induces Nlrp3 inflammasome activation via FOXO1 phosphorylation, resulting in interleukin-1β secretion and pyroptosis in hepatocytes. Toxicol. Sci. 179, 53–69 (2021).
Veskovic, M. et al. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and AKT/MTOR signaling in methionine-choline deficiency-induced fatty liver disease. Eur. J. Pharm. 848, 39–48 (2019).
Na, J. D., Choi, Y. J., Jun, D. S. & Kim, Y. C. Alleviation of paraquat-induced oxidative lung injury by betaine via regulation of sulfur-containing amino acid metabolism despite the lack of betaine-homocysteine methyltransferase (Bhmt) in the lung. Food Funct. 10, 1225–1234 (2019).
W, D. et al. The alleviating effects and mechanisms of betaine on dextran sulfate sodium-induced colitis in mice. Mol. Nutr. Food Res. 67, e2300376 (2023).
Yang, Z. J. et al. Betaine alleviates cognitive impairment induced by homocysteine through attenuating Nlrp3-mediated microglial pyroptosis in an M6a-Ythdf2-dependent manner. Redox Biol. 69, 103026 (2024).
Funding
This work was partially supported by National Natural Science Foundation of China (No. 82471744)Â and Shanghai Municipal Health Commission (No. 202340047).
Author information
Authors and Affiliations
Contributions
Jufeng Zhang contributed to the animal study, molecular biology examination, and data analyses; Lin Zhou contributed to data analyses; Hui Xu contributed to in vitro study; You You and Siyi Xia contributed to immunofluorescence staining and Western blotting; Hongping Xia contributed to the design of the study and revised the article for important intellectual content; all authors have read and approved the final version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
The study was reviewed and approved by Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (XHEC-F-2024-025). All methods were carried out in accordance with relevant guidelines and regulations.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, J., Zhou, L., Xu, H. et al. Betaine improves hyperoxic lung injury through downregulating pulmonary macrophage pyroptosis in newborn mice. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04364-8
Received:
Revised:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41390-025-04364-8


